Fund+
People
- Board members
- Our team
Investment Strategy
Portfolio
- Current
- Exits
Your Project
News
Contact us

Confo Therapeutics

Confo Therapeutics Press Release

June 12, 2020

Confo Therapeutics Expands Board with Appointment of Rob Scott as Independent Director

Confo Therapeutics Expands Board with…

Confo Therapeutics Press Release

June 3, 2020

Confo Therapeutics Appoints Paolo Vicini as Chief Development Officer

Confo Therapeutics Appoints Paolo Vicini…

Confo Therapeutics Press Release

September 23, 2019

FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019

FierceBiotech names Confo Therapeutics as…

Confo Therapeutics Press Release

July 3, 2019

Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

Ghent, Belgium, and Dresden, Germany…

Confo Therapeutics Press Release

June 20, 2019

Confo Therapeutics receives €1.7 million grant from VLAIO

Ghent, Belgium, 20 June 2019…

Confo Therapeutics Press Release

May 7, 2019

Confo Therapeutics raises €30 million in Series A financing

Round led by BioGeneration Ventures…

1
2

Contact us

Address:
Groot Begijnhof 60
3000 Leuven
Belgium
Phone: +32 (0)16 90 50 00
Email: info@fundplus.be

Recent Articles

Fund+ Portfolio Company Tubulis to be Acquired by Gilead
TargED Biopharmaceuticals to Present First Clinical and New Preclinical Data on TGD001 in Two Oral Sessions at the 2025 ASH Annual Meeting
Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)

© 2019 FUND⁺- ALL RIGHTS RESERVED. |

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT Read More

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT